1. Girolami A, Tormene D, Vianello F. Prothrombotic activity of oral contraceptives in patients with congenital thrombophilia varies with the defect. Clin Appl Thromb Hemost2001;7:76-76.
2.
2. Mira Y, Aznar J, Estelles A, et al. Congenital and acquired thrombotic risk factors in women using oral contraceptives: Clinical aspects. Clin Appl Thromb Hemost2000;6:162-162.
3.
3. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med2000;160:49-49.
4.
4. Martinelli I, Taioli E, Bucciarelli P, et al. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol1999;19:700-700.
5.
5. Aznar J, Gilabert J. Oral contraceptive users and screening of factor V Leiden. Thromb Haemost1999;81:845-845.
